Introduction
============

Photodynamic therapy (PDT) is a promising therapeutic technique for Barrett\'s esophagus, age-related macular degeneration, and cancer [@B1]-[@B3], which utilizes photosensitizers in presence of light with an appropriate wavelength to generate reactive oxygen species (ROS) *via* intersystem crossing- mediated singlet-to-triplet transition and subsequent energy transfers to eliminate or destroy diseased tissue by necrosis and apoptosis [@B4]-[@B6]. Compared to chemotherapy, radiotherapy, and surgery, PDT possesses less invasive, precise spatiotemporal control, negligible drug resistance, and fewer side effects [@B7]-[@B9]. To date, several types of photosensitizers have been developed for achieving effective PDT [@B10]-[@B12], such as boron dipyrromethene [@B13],[@B14], phthalocyanine[@B15],[@B16], and porphyrin[@B17]. As near-infrared (NIR) fluorescent bioimaging has significant advantages in high spatial resolution, deep penetration depth, high sensitivity, and direct visualization [@B18]-[@B22], the combination of NIR fluorescent bioimaging and photodynamic therapy in single molecular should help to improve the efficient of detection and simultaneous treatment of disease [@B23],[@B24]. However, due to the hydrophobicity of aromatic macrocyclic structures, photosensitizers trend to aggregate in aqueous media which leads to quench fluorescence and reduce the efficiency for ROS generation[@B25]. Moreover, the existence of fluorescent quenching effect also makes it difficult to develop organic fluorescent nanoparticles with bright NIR emission and efficient ROS production ability for image-guided PDT based on traditional photosensitizers. Hence, many strategies have been developed to improve the diagnosis and treatment efficiency, such as modification with hydrophilic groups or load in nanocarrier platform such as micelles [@B26],[@B27], upconversion nanoparticles [@B28], metal nanodots [@B29], silica nanoparticles [@B28], and metal-organic frameworks [@B31],[@B32]. Despite of the achieved effect of these studies, the development of novel photosensitizers with enhanced ROS production efficiency as well as NIR fluorescence in aggregated state is highly desirable.

Recently, organic fluorescent nanoparticles based on AIE active fluorogens, which exhibit bright fluorescence in aggregated state, have been investigated and shown great application prospects in cell tracking [@B33], tumor imaging [@B34],[@B35], and image- guided treatment[@B36]. Opposite to conventional photosensitizers, AIE active fluorophores containing electron donor (D)-acceptor (A) structure exhibit efficient ROS production in aggregate state [@B37]-[@B39]. Meanwhile, the ideal AIE active fluorogens also show far red/NIR fluorescence with large Stokes shifts, which are highly desirable for optical bioimaging [@B40]. These unique characteristics enable a great potential for image-guided PDT by encapsulation of AIE active fluorophores by polymer matrix to provide platform with NIR fluorescence for bioimaging[@B3], ROS production for ablation [@B41], negligible dark toxicity [@B42], good photostability[@B41], and biocompatibility [@B44]. For example, NIR AIE active probe containing tetraphenyl ethene (TPE) as electron donor and dicyanovinyl (DC) as acceptor, TPETCAQ, is encapsulated by DSPE to yield organic fluorescent nanoparticles for image-guided PDT [@B41]. Hence, AIE active fluorogens containing D-A structure are promising candidate for fluorescent bioimaging as well as photodynamic therapy.

In this contribution, we designed and synthesized AIEgen with rhodanine as electron acceptor and tetraphenylethylene as electron donor, and enhanced D-A structure by introducing electron-rich groups of thiophene, making the emission wavelength red-shifted to near infrared region. The novel NIR fluorogen, TPVTR, shows distinctly AIE feature and ROS generation property in the aggregate state. The corresponding organic fluorescent nanoparticles were fabricated by encapsulation TPVTR within Pluronic F127, which exhibit high photostability and good biocompatibility, and demonstrate superior performances in photodynamic ablation and long-term monitoring of tumor *in vitro* and *in vivo*.

Results and Discussion
======================

Fabrication and Characterization of TPVTR dots
----------------------------------------------

The synthetic route toward TPVTR is presented in **Scheme [1](#SC1){ref-type="fig"}**A. Suzuki coupling between bromotriphenylethylene and 5-formylthiophene-2-boronic acid yielded the precursor TPVT-CHO. Then, the Knoevenagel condensation reaction between TPVT- CHO and rhodanine was carried out to afford the targeted product TPVTR. Detailed preparation process and characterization data are provided in the Experimental Section.

The fluorescent property of TPVTR in THF/water mixed solvents are shown in Figure [1](#F1){ref-type="fig"}A and Figure [1](#F1){ref-type="fig"}B. It can be seen that when the water percentage (*f*~w~) is less than 60%, the PL intensity is very weak and keeps stable. Upon further increase of the *f~w~*, the fluorescent intensity of TPVTR significantly enhances due to the formation of aggregates. Due to the D-A structure of TPVTR, the further enhancement of *f~w~* will increase the TICT effect leading to the decrease of fluorescent intensity. Therefore, these results confirm that TPVTR is AIE active.

Due to the hyrophobic property of TPVTR, TPVTR was encapsulated in Pluronic F127 to fabricate TPVTR nanoparticles (TPVTR dots) via nanoprecipitation method. The size and morphology of TPVTR dots were recorded and observed by dynamic light scattering (DLS) and transmission electron microscopy (TEM). As shown in Figure [1](#F1){ref-type="fig"}C, TPVTR dots have good appearance and uniform particle size (\~100 nm). The particle size change of TPVTR dots which are stored in PBS at room temperature up to 15 days was monitored by DLS (Figure [S5](#SM0){ref-type="supplementary-material"}A), and there is no obvious aggregation and precipitation, indicating that TPVTR dots have excellent colloidal stability.

As shown in Figure [1](#F1){ref-type="fig"}D, the UV-vis absorption spectrum of TPVTR dots covers range of 400\~600 nm with a maxmium around 485 nm, the emission spectrum arranges from 600 to 900 nm with a peak around 695 nm, belongs to the NIR region, which is beneficial to be efficient photosensitizer for PDT application. Interesting, TPVTR dots exhibited long Stokes shift which is about 210 nm. To further verify the fluorescent stability of TPVTR dots, TPVTR dots were stored in PBS solutions with long-term or in PBS with different pH ranging from 3 to 12. The results show that the fluorescent intensity of TPVTR dots in PBS solutions changes slightly after 15 days (Figure [S5](#SM0){ref-type="supplementary-material"}A). Meanwhile, the photoluminescence intensity of TPVTR dots keeps stable with the change of pH value (Figure [S5](#SM0){ref-type="supplementary-material"}B). All these results confirm that TPVTR dots have good stability, which is beneficial for subsequent applications in biological imaging.

The ROS generation efficiency of TPVTR dots in PBS solutions was subsequently evaluated under the visible-light (400\~750 nm, 200 mW·cm^-2^) irradiation using 9,10-anthracenediylbis(methylene)dimalonic acid (ABDA) (50 μM) as an indicator. As shown in Figure [1](#F1){ref-type="fig"}E, the decrease of ABDA absorption over a time period from 0 s to 270 s is observed. The absorbance of ABDA and TPVTR dots mixture decreases a lot (72%) after irradiation for 270 s, which means that ABDA is consumed by the ROS generated from TPVTR dots (5 μM). As a control, the absorption of ABDA without TPVTR dots remains about 90% under irradiation of the same time, which confirms that the absorbance of ABDA under light irradiation is relatively stable. The intensity of *A*/*A*~0~ in Figure [1](#F1){ref-type="fig"}F also demonstrates that TPVTR dots can generate ROS effectively. All the results confirm that TPVTR dots exhibit the ability of generation ROS and can be potentially used as photodynamic therapy agent.

*In vitro* Cell Tracing and *In vivo* Monitoring Living Tumor Growth
--------------------------------------------------------------------

With the advantages of NIR emission of TPVTR dots, the activation of TPVTR dots in cells was also studied by co-cultured TPVTR dots with HepG2 cells. As illustrated in Figure [2](#F2){ref-type="fig"}, TPVTR dots can penetrate into cells, accumulate in the cytoplasm and show bright NIR fluorescence. In addition, the photostability of TPVTR dots under continuous laser irradiation up to 10 min was also investigated. After HepG2 cells incubated with TPVTR dots were irradiated by 10 min continuous laser, the fluorescent intensity of TPVTR dots in cells exhibits less change than DAPI. These dates indicate that TPVTR dots could be a promising optical material for bioimaging applications.

Thanks to the good performance (e.g. high photostability, NIR emission and so on) of TPVTR dots *in vitro*, TPVTR dots were further introduced into long-term tumor tracking *in vitro* and *in vivo*. HepG2 cells incubated with TPVTR dots (10 µg·mL^-1^) for 4 h were as the first generation cells. After the cells were cultured for a period of time, the fluorescent signals of cells were assessed by confocal fluorescence microscope and flow cytometry. Although the fluorescent intensity of cells gradually decreases, the cells still exhibit bright red fluorescence even up to 16 days (Figure [3](#F3){ref-type="fig"}A and Figure [S6](#SM0){ref-type="supplementary-material"}). The results of flow cytometry are consistent with confocal fluorescence microscope (Figure [S7](#SM0){ref-type="supplementary-material"}). All the results confirm that TPVTR dots can be utilized as a promising fluorescent probe for long-term tracking *in vitro*.

The experiment of TPVTR dots for long-term tracing *in vivo* was subsequently carried out. HepG2 cells (5 × 10^6^ cells per mouse) labeled with TPVTR dots (10 μg·mL^-1^) were subcutaneously injected into flank of nude mice. After transplantion, a time-dependent optical imaging of a small animal *in vivo* was carried out. The transplanted site of tumor cells in mice emits bright red fluorescence (excitation around 510 nm and emission around 700 nm). After TPVTR dots-labeled HepG2 cells injected for 8 d, the fluorescent signals still remain detectable (Figure [3](#F3){ref-type="fig"}B). Finally, the tumor-labled nude mice were euthanized. Then the tumor and other organs were analyzed by Bluck *in vivo* imaging system (Figure [3](#F3){ref-type="fig"}C). The fluorescent images of tumor and normal organs (e.g. heart, liver, spleen, lung and kidney) show that only the tumor displays the fluorescent signal. These results confirm the ability of TPVTR dots in long-term monitoring tumor growth in living organisms.

In order to further confirm that TPVTR dots have no side effect on the growth of nude mice, the nude mice were observed for 3 weeks after tail vein injection of 200 μL of TPVTR dots solution (20 μg·mL^-1^ in PBS solutions). The nude mice were euthanized and took out the major organs for H&E staining (Figure [S8](#SM0){ref-type="supplementary-material"}). The major organs (such as lung, liver, heart, kidney, and spleen) show no significant apoptosis or necrosis, which further demonstrates that TPVTR dots exhibit little side effects. These results confirm that TPVTR dots are promising fluorescent nanomaterials for applications *in vivo*.

Intracellular ROS Detection and *In vivo* Photodynamic Therapy
--------------------------------------------------------------

To evaluate the ROS generation by TPVTR dots inside cells, a common oxidant-sensitive dye, DCFH- DA (2,7-dichlorofluorescein diacetate, a cell- permeable green fluorescent probe) was selected to validate the intracellular ROS generation directly. Figure [4](#F4){ref-type="fig"}A shows that bright green fluorescence is observed in HepG2 cells under visible-light (400\~750 nm, 100 mW·cm^-2^) irradiation after co-cultured with TPVTR dots, suggesting that intracellular ROS is generated. Meanwhile, HepG2 cells merely treated with light irradiation or TPVTR dots yield weak or even no fluorescence signal. These images prove that TPVTR dots in cells produce ROS under light irradiation, which has a great potential for photodynamic therapy.

Meanwhile, photodynamic therapy efficacy of TPVTR dots toward HepG2 cells *in vitro* was further investigated by CCK-8 assays (Figure [4](#F4){ref-type="fig"}B). The cells viabilities remain almost 80% even treated with 50 μg·mL^-1^ of TPVTR dots, demonstrating low cytotoxicity in dark and good biocompatibility of TPVTR dots in living cells. By contrast, the viability of HepG2 cells dramatically decrease below 50% after treated with 25 μg·mL^-1^ of TPVTR dots under light illumination (100 mW·cm^-2^, 10 min), indicating the effective PDT efficiency.

At last, the *in vivo* photodynamic therapy effect was evaluated by tracing tumor ablation. The HepG2 cells (5 × 10^6^ cells per mouse) were subcutaneously implanted into nude mice. Then the nude mice were randomly divided into four groups and treated with either injection of saline, light irradiation (400\~750 nm, 100 mW·cm^-2^), intratumoral injection of TPVTR dots or light irradiation(400\~750 nm, 100 mW·cm^-2^) after intratumoral injection of TPVTR dots while the volume of tumors reached approximately 100\~200 mm^3^. The body weight and tumor size of nude mice were recorded every two days to evaluate the PDT efficiency *in vivo* up to 22 days. In order to avoid damage to the skin of mice, the irradiation of tumor site in nude mice was suspended for one minute after every irradiation. In addition, the temperature of tumor site before and after light irradiation (400\~750 nm, 10 min) are all below 42^o^C, the results show that the temperature difference is only 1.67 C. As illustrated in Figure [5](#F5){ref-type="fig"}, the tumor of mice in injection of saline group grew rapidly, and there was no obvious difference with other control groups. In a marked contrast, the tumor growth in PDT group is significantly ablated after 21 days. In addition, there was no distinct difference in body weight between the all groups.The marked reduced tumor size by TPVTR dots results confirmed their effective PDT efficiency*in vivo*.

Conclusions
===========

In summary, an effective NIR emissive organic fluorophore, TPVTR, with AIE characteristic has been designed and synthesized. The corresponding organic fluorescent nanoparticles, TPVTR dots, were fabricated and enjoyed NIR emission around 695 nm with a large Stokes shift (210 nm), excellent photostability, and good biocompatibility, which is suitable for long-term cell tracing *in vitro* and*in vivo*. Moreover, TPVTR dots offer good PDT effect *in vitro* and *in vivo* due to the high ROS generation efficiency, revealing that TPVTR dots are promising in image-guide therapy. This research highlights the efficient strategy for developing promising near-infrared organic fluorescent nanoparticles in advancing the field of bioimaging and further image-guide clinical applications.

Methods
=======

Materials
---------

All reagent and solvents were commercially available and used directly without further purification unless specified. Bromotriphenylethylene and 5-formylthiophene-2-boronic acid were purchased from Tokyo Chemical Industry (Japan). Cell Counting Kit-8 was purchased from Dojindo Laboratories (Kumamoto, Japan). DAPI, 4% paraformaldehyde and Trypsin-EDTA Solution were purchased from Solarbio Co. Ltd. (China). DCFH-DA (2, 7-dichlorofluorescein diacetate) Detection Kit were purchased from Beyotime Biotechnology Co. Ltd. (China). Hematoxylin and Eosin Staining Kit were purchased from KeyGen Biotech. Co. Ltd. China).

Characterization
----------------

NMR spectra were measured via a Bruker 400 MHz NMR with DMSO-*d*~6~ or CDCl~3~. Infrared spectroscopy (IR) was performed with a Shimadzu FTIR-8100 spectrophotometer. High-resolution mass spectra was conducted on a Bruker Autoflex instrument. UV absorption spectra were recorded on Thermofisher Evolution 300 spectropolarimeter. FL spectra were obtained using a Thermofisher Lumina spectrofluorometer.

Synthesis of TPVT-CHO
---------------------

The PdCl~2~ (PPh~3~)~2~ (262 mg, 0.375mmol), 2M Cs~2~CO~3~ solution (25 mL), bromotriphenylethylene (5.03 g, 15 mmol), 5-formylthiophen-2-ylboronic acid (4.68 g, 30 mmol), distilled toluene (75 ml) and EtOH (50 ml) were mixed in a 200 mL flask. After degassed by bubbling N~2~ for 1h, the reaction was carried out at 80^o^C for 24 h. Then, the reaction mixture was poured into ice water, extracted with DCM for three times. The solvent was evaporated under vacuum and the resulting residue was purified by silica gel column chromatography using *n*-Hexane/Ethylacetate (4:1; v/v) for elution, affording TPVT-CHO as a yellow solid with 76% yield. ^1^H NMR (400 MHz, DMSO-*d*~6~), *δ* (ppm): 9.85\~9.86(s, CHO, 1H), 7.52\~7.83(m, Ar, 13H), 7.43\~7.47(m, Ar, 3H), 7.12\~7.14(d, Ar, 1H). ^13^C NMR (150 MHz, DMSO-*d*~6~), *δ* (ppm): 178.84, 157.66, 153.88, 144.53, 144.50, 144.48, 137.41, 137.11, 130.81, 130.44, 128.55,128.37,128.05 127.33, 126.73, 119.88, 115.87, 112.16.

Synthesis of TPVTR
------------------

Rhodanine [@B42] (1.21 g, 5 mmol), *TPVT-CHO* (1.83 g, 5 mmol), and NH~4~Ac (500 mg) were added in HOAc (20 ml) under N~2~ atmosphere. The resulting mixture was stirred at 120 C for 12 h. After cooling to room temperature,the precipitate was collected and washed with cold MeOH. The crude product was recrystallized in DCM/EtOH (1/4, v/v) to obtain *TPVTR* as red solid. Yield: 2.25 g (74%). ^1^H NMR (400 MHz, CDCl~3~), *δ* (ppm): 7.59\~7.66(m, 3H), 7.44\~7.47 (m, 3H), 7.36\~7.37(m, 1H), 7.34\~7.35(m, 1H), 7.30\~7.32 (m, 2H), 7.24\~7.27(m, 5H), 7.19\~7.20(d, 2H), 7.10\~7.11 (m, 3H), 7.01\~7.04(m, 2H), 6.70\~6.71(d, 1H). ^13^C NMR (100 MHz, CDCl~3~), *δ* (ppm): 155.75, 144.86, 141.99, 141.90, 141.35, 137.22, 134.48, 132.80, 131.77, 131.69, 131.21, 130.57, 130.11, 129.41, 129.19, 128.64, 128.18, 127.64, 127.61, 127.05, 113.21, 122.98. IR (v^-1^, KBr), 3355, 3024, 2217, 1719, 1645, 1586, 1537, 1459, 1387, 1212, 1152, 1074, 757, 691. HRMS (ESI): \[M+H\]^+^ calcd for C~37~H~23~N~3~OS~2~, found, 590.1345.

TPVTR dots fabrication
----------------------

TPVTR dots were fabricated via nanoprecipitation method by using Pluronic F-127 as the encapsulation. Generally, Pluronic F-127 (200 mg) and TPVTR (20 mg) were added into THF (2 mL). After mixing for 0.5 h, THF solution was drop added into the DI water (10 mL) under ultrasonic condition. The mixture was bubbling N~2~ for 2 h to completely remove the THF. After that, the free TPVTR was completed removed by dialysis to obtain the TPVTR dots.

Extracellular ROS detection
---------------------------

The extracellular ROS production of TPVTR upon irradiation was determined using a commercial ^1^O~2~ probe, 9,10-anthracenediyl-bis(methylene) dimalonic acid (ABDA), as the indicator. A DMSO solution of TPVTR (1 mM, 5 µL) and a DMSO solution of ABDA (10 mM, 5 µL) were added into 990 µL water. Then the mixed solution was exposed to white light (400\~750 nm) from 0 s to 270 s. The descending ABDA absorbance detected by ultraviolet spectrophotometer indicates the extracellular ROS production of TPVTR. As the control group, the DMSO solution of TPVTR (1 mM, 5 µL) was replaced by 5 µL pure DMSO. The UV absorption of ABDA was detected after the same irradiation conditions.

Cell culture
------------

TPVTR dots was diluted with culture medium to obtain a working solution (10µg·mL^-1^) for the subsequent cellular experiments. HepG2 cells were gifted from Nanfang Hospital (Guangzhou, China), and cultured in DMEM culture medium in a 5% CO~2~ incubator at 37^o^C.

Photostability study
--------------------

To investigate the photostability of TPVTR dots, the parameters and procedures were as follows: HepG2 cells co-stained by TPVTR dots and DAPI were analyzed every 1 min under continuous laser irradiation. The fluorescent intensity of each image was evaluated. The photostability of TPVTR dots was assessed by the ratio between the fluorescent intensity at different time intervals during continuous laser irradiation and the initial value as a function of the exposure time.

Long-term cell tracking *in vitro*
----------------------------------

HepG2 cells were seeded in confocal microscope dish with 5 × 10^4^ cells. After attachment, the old medium was replaced by TPVTR dots (10µg·mL^-1^). After incubation at 37 C for 4 h, the cells were washed with PBS buffer, detached by EDTA-trypsin and resuspended in culture medium. Upon dilution, the cells were subcultured in wells containing cell culture coverslips for different cell generations. At specified time intervals, the cells were trypsinized, suspended and fixed with 4% paraformaldehyde for 15 min. The stained cells were imaged using a confocal fluorescence microscope (LSM 880 with Airyscan, Carl Zeiss). On the other hand, after treatment with TPVTR dots for 4 h, the cells at the corresponding time interval were wished, digested and collected for flow cytometry analysis using BD LSRFortessa for quantitative study of fluorescent intensities. A batch of blank cells without any treatment was used as the control group.

Intracellular ROS detection
---------------------------

The intracellular ROS production of TPVTR dots was determined using DCFH-DA (2,7-dichlorofluorescein diacetate) Detection Kit. HepG2 cells were seeded in 6-well plate at 37 C in humidified environment containing 5% CO~2~. After overnight culturing, the cells were treated with PBS or TPVTR dots (10µg·mL^-1^) for 4h, respectively. Then, the cells were washed with PBS, and incubated with 10µM DCFH-DA in serum-free DMEM medium for 20 min at 37 C in humidified environment containing 5% CO~2~. The cells were washed with PBS again, and irradiated with white light (400\~750 nm) for 4 min. After irradiation, the cells were imaged using an inverted fluorescence microscope (Axio Observer, Carl Zeiss) (excited at 488 nm, monitored at 525 nm).

*In vitro* cytotoxicity
-----------------------

The cells were seeded in 96 well plates and incubated overnight at 37 C in humidified environment containing 5% CO~2~. Subsequently, the cells were treated with TPVTR dots in 100 mL of fresh culture medium at various concentrations (from 1.6\~50 μg/mL) and subjected to the dark or light irradiation (400\~750 nm, 100 mW·cm^-2^) for 10 min. After treatment, the cells were returned to the incubator for another 24 h. The culture medium was removed, and 100 μL of 10 μM CCK-8 was added into each well and incubated for 4 h. The absorbance at 450 nm of each well was measured using a BIOTEK ELX80 enzyme-linked immunosorbent assay reader. The relative cell viability was calculated as follows: cell viability (%) = OD(sample) × 100/OD(control), in which OD (control) was obtained when without samples and OD (sample) was obtained with the addition of TPVTR dots at various concentration.

*In vivo* long-term monitoring tumor
------------------------------------

The *in vivo* experiment was conducted on the adult BALB/c nude mice (15\~16 g). All animal experiments were approved by the local Animal Ethics Committee of *Southern Medical University, China*. After incubation with 20 μg·mL^-1^ TPVTR for 4 h at 37 C, HepG2 cells (5 × 10^6^ cells in 0.1 mL DMEM) were subcutaneously injected into the nude mice. Fluorescent imaging were recorded using an IVISH Spectrum Imaging System after 1, 3, 5, and 8 days. After 8 days, tumor and other organs including heart, liver, spleen, lung, kidney were excised for *ex vivo* fluorescence imaging.

Phototherapeutic efficacy of TPVTR dots *in vivo*
-------------------------------------------------

HepG2 liver cancer cells (5 × 10^6^ cells per mouse) were subcutaneously injected into the nude mice. When the tumor volumes reached 100\~200 mm^3^, the mice were randomly assigned to 4 groups and treated with different treatments every four days: 1) saline, 2) saline with light irradiation, 3) TPVTR dots, 4) TPVTR dots with light irradiation. The mice in groups 3 and 4 were intratumoral injected with TPVTR dots at the equivalent dose of 10mg/kg. After injection, the light irradiation (400\~750 nm, 100 mW·cm^-2^, 10 min) was administrated one minute after every one minute irradiation. The body weight and tumor size of nude mice were recorded with electronic balance and vernier calipers every two days.

Hematoxylin and eosin (H&E) staining analysis
---------------------------------------------

After injected TPVTR dots solution into the tail vein of nude mice at the equivalent dose of 10 mg/kg, the physical conditions of the nude mice were monitored and observed, including their general status, e.g., skin and activities for 16 days. Subsequently, the mice were sacrificed and then the liver, spleen, lung, kidney and heart were collected for H&E staining. The major organs were fixed in formalin and cryosectioned at 10 mm thickness onto slides and stained with H&E (KeyGen Biotech. Co. Ltd., Nanjing, China) according to the manufacturer\'s instructions.
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![**(A)** Synthetic routine to TPVTR. **(B)** Schematic illustration of the fabrication of TPVTR dots, long-Term Monitoring and Photodynamic Therapy of Cancer.](ntnov03p0156g001){#SC1}

![**(A)** PL spectra of TPVTR in water/THF mixture. **(B)** Trend diagram of fluorescent peaks versus the contents of water in water/THF mixture, Picture insert of (B): PL image of TPVTR in water/THF mixture. **(C)** Particle-size distribution of TPVTR dots in water studied via DLS experiment, picture insert of (C): TEM image of TPVTR dots, scale bar: 100 nm. **(D)** Normalized UV and FL spectra of TPVTR dots in water. **(E)** Decomposition of ABDA by TPVTR dots under light irradiation(400\~750 nm, 200 mW·cm^-2^) from 0 s to 270 s. **(F)** ABDA decomposition rate by TPVTR dots under light irradiation, A~0~ is the absorbance of ABDA before white light irradiation, A is the absorbance of ABDA after light irradiation for designated time.](ntnov03p0156g002){#F1}

![Photostability of TPVTR dots in HepG2 cells under continuous laser irradiation.](ntnov03p0156g003){#F2}

![**(A)** CLSM images TPVTR dots-stained HepG2 cells at different time. **(B)** *In vivo* fluorescent imaging of tumor labeled by TPVTR dots. **(C)** Representative *ex vivo* fluorescent images of the isolated organs from the nude mice after 8 days tumor labeling](ntnov03p0156g004){#F3}

![**(A)** Intracellular ROS detection using DCFH-DA as the sensor. **(B)***In vitro* cytotoxicity of TPVTR dots without or with light irradiation (100 mW·cm^-2^, 10 min)](ntnov03p0156g005){#F4}

![**(A)** Photographs of tumors on day 21 following indicated treatments. **(B)** Changes in tumor volumes in living mice following treatment with either saline, saline with light, TPVTR dots, TPVTR dots with light during the course of treatments (21 days), values were mean ± SD (n = 5, \*P \< 0.05); **(C)** Body weight changes of the four groups during the course of treatments (21 days), n = 5, data are the mean ± SD](ntnov03p0156g006){#F5}
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